Claris Lifesciences Ltd todaysaid its consolidated net profit jumped by 233 per cent at Rs35 crore in Q3 FY2017 as against Rs 15 crore in thecorresponding period of last year. Money Control, 2 months ago
More from: DNA, Business Standard...and 1 other sources
On February 8, 2017 Copthall Mauritius Investment Limited sold 7,19,433 shares of Claris Lifesciences at Rs 313.Money Control, 2 months ago
on your WebpageAdd Widget >Get your members hooked!